Latest Continuous Disclosure News

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Vitasora Health has secured AU$3.56 million from a cornerstone investor, issuing over 118 million shares, while confirming compliance with key regulatory disclosure obligations.

VanEck Investments Limited has released an updated Product Disclosure Statement detailing its suite of Australian fixed income ETFs, outlining fund strategies, risk factors, and fee structures.

VanEck Investments Limited has released a comprehensive Product Disclosure Statement for its suite of seven Australian bond ETFs, detailing fund strategies, risks, fees, and operational frameworks under the ASX AQUA Rules.

VanEck Investments Limited has released an updated Product Disclosure Statement detailing seven Australian fixed income ETFs listed on the ASX, offering investors diversified exposure across government bonds, corporate debt, and subordinated securities.

Viridis Mining and Minerals Limited has addressed ASX concerns following unusual trading linked to a Brazilian environmental recommendation on its Colossus Project. The company remains confident in securing the project's Preliminary License despite the non-binding recommendation.

Alvo Minerals Limited has issued a small, invitation-only share offer to remove trading restrictions on recently issued shares, while highlighting ongoing funding and operational risks tied to its Brazilian copper-zinc projects.

Cauldron Energy’s CEO posted a video during a trading halt that prematurely hinted at exploration results, breaching ASX disclosure rules. The company acknowledges the misstep and outlines steps to tighten compliance.

Ryzon Materials Ltd has lodged a prospectus to raise up to $10 million through a share placement with free-attaching options, aiming to meet ASX conditions for lifting its securities suspension and advancing its Nachu graphite project.

Anatara Lifesciences has completed the final tranche of its placement, issuing over 66 million shares and granting options to its lead manager, marking a key step in its capital raising strategy.

InhaleRX Limited has announced a non-renounceable entitlement offer to raise approximately $247,668 by issuing nearly 10 million new shares at 2.5 cents each, accompanied by free attaching options. The offer opens on 5 December and closes on 17 December 2025.

Electro Optic Systems has resolved ASIC's investigation into its 2022 revenue guidance breaches by agreeing to a $4 million penalty, paving the way for renewed focus on growth and governance.